ArticleClinical chemistry and laboratory medicine2026
Strategy of Laboratory Medicine - EFLM Vision.
Article in Clinical chemistry and laboratory medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The strategic direction of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) is guided by global healthcare trends, rapid technological advancements, and the evolving role of laboratory professionals in modern medicine. The aim is to position laboratory medicine as a leader in precision diagnostics, digital healthcare transformation and integrated diagnostics, ensuring timely, accurate, and cost-effective medical testing that improves patient outcomes. EFLM reaffirms that every innovation in laboratory medicine must ultimately serve the patient - ensuring equitable access to high-quality diagnostics, enhancing patient understanding, and strengthening trust in laboratory-generated data. In a world deeply reshaped by technological, economic, and geopolitical forces, EFLM must act as both a scientific authority and a societal compass, guiding the transformation of diagnostics into patient-centered, data-driven, and resilient care models. EFLM's strategy focuses on integrating laboratory innovation and value-based laboratory medicine, strengthening workforce competencies, promoting sustainability and clinical outcomes improvement, and addressing key challenges in patient-centered healthcare. The following strategic priorities reflect the Federation's commitment to improving the impact of laboratory medicine on clinical care, public health, and scientific advancement.
Indexed as
Identifiers
41460736What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.